Clinical Trial Update: Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase II clinical study evaluating Utidelone Capsule (UTD2) in advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer; the study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Utidelone Capsule (UTD2) (utidelone)

Snippet

Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: NOT_YET_RECRUITING